Digital therapeutics
Digital therapeutics are software programs designed to treat medical conditions. Providers increasingly use them to improve patient outcomes and offer personalized medicine within the mental healthcare and chronic disease management areas. However, regulatory hurdles, data privacy concerns and efficacy validation challenges must be addressed to expand adoption and use.
Top Stories
-
News
07 Nov 2025
Omada Health to prescribe GLP-1s
The virtual care provider said it will add a prescribing capability to its GLP-1 care track to offer comprehensive support to patients taking anti-obesity medications. Continue Reading
-
News
03 Nov 2025
2026 Physician Fee Schedule extends some virtual care payments
The PFS final rule adds ADHD treatment to its digital mental health payment pathway and allows FQHCs to continue to bill for telehealth services until the end of 2026. Continue Reading
-
News
08 Aug 2025
Omada Health revenue jumps 49% year-over-year post-IPO
The virtual chronic care provider reported strong financial results in Q2 2025, including sizeable revenue and membership growth, and a strong IPO showing. Continue Reading
-
Feature
17 Jul 2025
How Stanford Health went all-in on a virtual-first COPD program
Stanford Health Care is collaborating with a virtual-first provider for pulmonary rehabilitation to expand access to chronic care for COPD patients and improve outcomes. Continue Reading
-
Feature
11 Jul 2025
Digital health IPOs signal thaw, but new success metrics apply
After an IPO drought, successful public debuts in 2025 mark a potential revival for digital health in the public markets, but companies now face stricter success metrics. Continue Reading
-
News
29 May 2025
Omada Health launches IPO, aims to raise up to $158M
Omada Health is the latest digital care provider to go public, with plans to offer 7.9 million shares at $18 to $20 a share. Continue Reading